We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Canada recommends AstraZeneca vaccine despite U.S. criticism of trial data

Tue, 23rd Mar 2021 17:33

(Updates with restrictions in Regina, Saskatchewan; high
schools reopening for daily class in Quebec)

By Steve Scherer

OTTAWA, March 23 (Reuters) - Canada on Tuesday said the
AstraZeneca COVID-19 vaccine is safe and will continue
to be recommended for use despite criticism from U.S. officials
of the drugmaker's analysis of the shot's efficacy in a large
trial, health officials said.

"The message is that the efficacy and the safety of the
vaccine have been shown," senior Health Canada official Marc
Berthiaume said. "It continues to be beneficial for Canadians to
prevent COVID-19."

Deliveries of coronavirus vaccines are ramping up in Canada,
with some 2 million doses of the Pfizer Inc/BioNTech SE
and Moderna Inc vaccines coming this week. The
United States said it is sharing 1.5 million doses of the
AstraZeneca vaccine with Canada as early as this week.

The U.S. National Institute of Allergy and Infectious
Diseases said on Monday that the independent monitoring board
charged with ensuring the safety and accuracy of AstraZeneca's
latest trial said the company may have given an incomplete view
of the shot's effectiveness. The company has since said it will
publish up-to-date results https://www.reuters.com/article/idUSKBN2BF1RE
from its latest trial within 48 hours.

"We will look at the complete data package (from the U.S.)
sometime in April, and will assess and communicate the results,"
said Supriya Sharma, chief medical adviser at Health Canada, the
federal health ministry. "The bottom line is that doesn't change
recommendations on the AstraZeneca vaccine at this time."

There will be a delay of a day or two on delivery of Moderna
vaccines this week, Alberta's chief medical officer of health
said, adding that bookings for shots will not be affected.

Canada also said it would give C$23.7 million ($18.9
million) to Ontario to open more voluntary isolation sites for
those who become infected with the virus and need a place to
quarantine as cases surge.

Saskatchewan's provincial government imposed new
restrictions in the city of Regina and surrounding area,
including a ban on private indoor gatherings, due to a spike in
infections caused by highly contagious new virus variants.

Quebec, which has avoided a third wave of infections, will
allow its older high school students to attend class daily
starting March 29.

Canada has recorded 940,000 virus infections and more than
22,700 deaths from COVID-19.

($1 = 1.2561 Canadian dollars)

(Reporting by Steve Scherer; Additional reporting by Rod Nickel
in Winnipeg and Allison Lampert in Montreal; Editing by Grant
McCool and Bill Berkrot)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.